1-(4-Amino-10-aza-tricyclo[6.3.2.0*2,7*]trideca-2,4,6-trien-10-yl)-2,2,2-trifluoro-ethanone → N-((1R,2R)-2-{5-Chloro-2-[10-(2,2,2-trifluoro-acetyl)-10-aza-tricyclo[6.3.2.0*2,7*]trideca-2,4,6-trien-4-ylamino]-pyrimidin-4-ylamino}-cyclohexyl)-methanesulfonamide
Reaction equation
[NH2:1][C:2]1[CH:3]=[C:4]2[C:10](=[CH:11][CH:12]=1)[CH:9]1[CH2:13][CH2:14][CH:5]2[CH2:6][N:7]([C:15](=[O:20])[C:16]([F:19])([F:18])[F:17])[CH2:8]1.Cl[C:22]1[N:27]=[C:26]([NH:28][C@@H:29]2[CH2:34][CH2:33][CH2:32][CH2:31][C@H:30]2[NH:35][S:36]([CH3:39])(=[O:38])=[O:37])[C:25]([Cl:40])=[CH:24][N:23]=1>>[Cl:40][C:25]1[C:26]([NH:28][C@@H:29]2[CH2:34][CH2:33][CH2:32][CH2:31][C@H:30]2[NH:35][S:36]([CH3:39])(=[O:38])=[O:37])=[N:27][C:22]([NH:1][C:2]2[CH:3]=[C:4]3[C:10](=[CH:11][CH:12]=2)[CH:9]2[CH2:13][CH2:14][CH:5]3[CH2:6][N:7]([C:15](=[O:20])[C:16]([F:19])([F:17])[F:18])[CH2:8]2)=[N:23][CH:24]=1Participants
Reactant 2
Product 1
Procedure
N-((1R,2R)-2-{5-Chloro-2-[10-(2,2,2-trifluoro-acetyl)-10-aza-tricyclo[6.3.2.0*2,7*]trideca-2,4,6-trien-4-ylamino]-pyrimidin-4-ylamino}-cyclohexyl)-methanesulfonamide was prepared from 1-(4-amino-10-aza-tricyclo[6.3.2.0*2,7*]trideca-2,4,6-trien-10-yl)-2,2,2-trifluoro-ethanone and N-[(1R,2R)-2-(2,5-dichloro-pyrimidin-4-ylamino)-cyclohexyl]-methanesulfonamide in an analogous manner to Example 290. Product isolated as a white foam as a mixture of diastereomers (429 mg, 69%). LCMS (m/e) 587 (M+1); 1H-NMR (CDCl3, 400 MHz) major rotomer δ 7.93 (s, 1H), 7.42-7.24 (m, 2H), 7.13-7.04 (m, 1H), 6.94-6.85 (m, 1H), 5.46-5.35 (m, 2H), 4.31-4.20 (m, 1H), 3.98-3.76 (m, 2H), 3.60-3.30 (m, 3H), 3.30-3.10 (m, 3H), 2.80 (s, 3H), 2.28-2.18 (m, 2H), 2.10-1.95 (m, 1H), 1.90-1.70 (m, 4H), 1.43-1.30 (m, 4H).
Workup
- customProduct isolated as a white foam as a mixture of diastereomers (429 mg, 69%)
Sources & evidence
- ORD record
- ord-287283723390425285e71d7f057c6942
- Source dataset
- uspto-grants-2013_10
- Patent number
- US08552186B2
Reaction notes
Loading…